Approval · Notice of Compliance 9896 · 2008
ZELDOX: Notice of Compliance 9896
Issued November 17, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9896
- Date
- November 17, 2008
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revisions to the product monograph
- Therapeutic class
- Antipsychotic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZELDOX | Not yet assigned | — |
Medicinal ingredients
- ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE 20 MG per CAP
- ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE 40 MG per CAP
- ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE 60 MG per CAP
- ZIPRASIDONE HYDROCHLORIDE MONOHYDRATE 80 MG per CAP